KROS
NASDAQ HealthcareKeros Therapeutics, Inc. - common stock
Biotechnology
📊 Market Data
| Price | $10.99 |
|---|---|
| Volume | 692,207 |
| Market Cap | 334.82M |
| Beta | 0.900 |
| RSI (14-Day) | 10.0 Oversold |
| 200-Day MA | $16.02 |
| 50-Day MA | $16.78 |
| 52-Week High | $22.55 |
| 52-Week Low | $9.12 |
| P/E Ratio | 4.78 |
| Forward P/E | -2.17 |
| Price / Book | 0.71 |
🎯 Investment Strategy Scores
How KROS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
36/100
High dividend yield + low volatility
🚀 Moon Shot
76/100
High growth potential (high beta + oversold)
🔪 Falling Knife
96/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
2/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
7/100
Large-cap, institutional-quality stocks
Find KROS in your text
Paste any text on the homepage — the tool will extract KROS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.